EUVIMEDEUVIMED entdecken
Crossref

PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATING OTHER AUTOIMMUNE DISEASES HAVE A MILDER DISEASE COURSE

Alina Soare, Simona Pintilie, Ana Maria Gherghe, Alexandra Radu, Rucsandra Dobrota, Mariana Sasu, Mihai Bojinca, Victor Stoica, Carina Mihai

Romanian Journal of Rheumatology · 2015

DOI: 10.37897/rjr.2015.2.8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Romanian Journal of Rheumatology, 2015. Verfasst von Alina Soare und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives. Systemic sclerosis (SSc) is a multisystem connective tissue disease (CTD), being one of the most heterogeneous diseases of the spectrum of CTDs. It may associate other autoimmune diseases (AIDs), therefore in this study we aimed to evaluate the prevalence of other AIDs in a cohort of patients with SSc and to evaluate their prognosis in comparison to patients with SSc without this association. Patients and methods. We performed a retrospective study in patients with SSc satisfying the ACR 1980 or the ACR/EULAR 2013 criteria, who were evaluated between January 2005 and May 2014 in our SSc center. These patients were investigated according to the EUSTAR recommendations, including modified Rodnan Skin Score (mRSS), lung function tests (LFT), echocardiography etc. As a control group for evaluating the prevalence of the AIDs we used all patients with Rheumatoid Arthritis (RA) visiting our clinic between January-December 2005. Data of all RA patients were collected from the electronic database of the hospital. All AIDs mentioned in the discharge diagnoses were recorded. Between-group comparisons were made with the chi-square test for nominal variables and with the independent-sample t-test for numeric variables.

Results

144 patients with SSc were included: 88.8% females, 66.6% with the limited cutaneous subset of disease (lcSSc), mean age 53.9 ± 12.8 years, mean disease duration at study enrollment 5.1±10.5 years and a mean follow-up time of 3.7 ± 2.6 years. Prevalence of the AID in the SSc cohort was 19.4%, patients with lcSSc being more prone to associate other AID (p = 0.001). We noted a tendency towards less interstitial lung disease (p = 0.056) and less digital ulcers (p = 0.081) in patients with SSc and AIDs. Comparing skin involvement for each year of follow-up in patients with SSc with and without and AIDs we observed that the first tended to have lower and more stable values of the mRSS.

Conclusion

Patients with SSc and AIDs tend to have a better outcome than the ones without this association. mRSS remains stable across the years in patients with SSc and AID, with lower values than the SSc patients.

Zitieren

APA

Soare, A., Pintilie, S., Gherghe, A. M., Radu, A., Dobrota, R., Sasu, M., Bojinca, M., Stoica, V., & Mihai, C. (2015). PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATING OTHER AUTOIMMUNE DISEASES HAVE A MILDER DISEASE COURSE. Romanian Journal of Rheumatology. https://doi.org/10.37897/rjr.2015.2.8

Vancouver

Soare A, Pintilie S, Gherghe AM, Radu A, Dobrota R, Sasu M, et al. PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATING OTHER AUTOIMMUNE DISEASES HAVE A MILDER DISEASE COURSE. Romanian Journal of Rheumatology. 2015. doi:10.37897/rjr.2015.2.8

BibTeX
@article{Soare2015,
  author = {Soare, Alina and Pintilie, Simona and Gherghe, Ana Maria and Radu, Alexandra and Dobrota, Rucsandra and Sasu, Mariana and Bojinca, Mihai and Stoica, Victor and Mihai, Carina},
  title = {PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATING OTHER AUTOIMMUNE DISEASES HAVE A MILDER DISEASE COURSE},
  journal = {Romanian Journal of Rheumatology},
  year = {2015},
  doi = {10.37897/rjr.2015.2.8}
}
Kostenlos starten →